PE: The Impact and Benefit of Physical Activity on Premature Ejaculation
Study Details
Study Description
Brief Summary
The purpose of this study is to investigate the relationship between physical activity and PE, and determine whether moderate physical activity might delay ejaculation time or be an alternative treatment for PE.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Dapoxetine 30 mg Patients who have sedentary life style will treat with Dapoxetine 30 mg (on demand) |
Drug: dapoxetine 30 mg on demand
Dapoxetine, a short-acting selective serotonin reuptake inhibitors, has been utilized for the treatment of premature ejaculation in various countries
|
Experimental: Moderate Running Patients who have sedentary life style will be advised moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week. (Minimally active category) |
Behavioral: physical activity
patients will do moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week
|
Sham Comparator: Sham-controlled Patients who have sedentary life style will be advised those to walk (not running )at most 30 minutes for 5 days in a week. (Inactive category) |
Behavioral: physical activity
patients will do moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week
|
Outcome Measures
Primary Outcome Measures
- Premature Ejaculation Diagnostic Tool (Total Score) [Baseline and 30 Days]
Premature Ejaculation Diagnostic Tool (PEDT) includes five items; control, frequency, minimal stimulation, distress, and interpersonal difficulty. In this classification tool, equal to or less than scores 8 indicates no PE, scores 9 and 10 indicate possible PE, and scores equal or higher than 11 indicates PE. Total score is between 2 and 22.
- Intravaginal Ejaculatory Latency Time [Baseline and 30 Days]
Duration determined by the sexual partner with stopwatch method, and <1 minute was considered as PE. (minimum/maximum scores were not possible)
Eligibility Criteria
Criteria
Inclusion Criteria:
- Sexually active, heterosexual patients without regular physical activity or erectile dysfunction, and had a sexual partner for at least six months, and sexual intercourse at least twice a week
Exclusion Criteria:
- Use of medications for endocrinological, metabolic, chronic systemic, or psychiatric diseases, use of alcohol or addictive substances, or use of drugs that might affect erection and ejaculation, presence of patients with Peyronie's disease, chronic prostatitis, urethritis, or active urinary tract infection, and absence of regular physical activity or previous treatment for premature ejaculation.
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Ankara Training and Research Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
- Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003 Aug;35(8):1381-95.
- Sunay D, Sunay M, Aydoğmuş Y, Bağbancı S, Arslan H, Karabulut A, Emir L. Acupuncture versus paroxetine for the treatment of premature ejaculation: a randomized, placebo-controlled clinical trial. Eur Urol. 2011 May;59(5):765-71. doi: 10.1016/j.eururo.2011.01.019. Epub 2011 Jan 18.
- Symonds T, Perelman MA, Althof S, Giuliano F, Martin M, May K, Abraham L, Crossland A, Morris M. Development and validation of a premature ejaculation diagnostic tool. Eur Urol. 2007 Aug;52(2):565-73. Epub 2007 Jan 16.
- 5191
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | Group 1 | Group 2 | Sham-controlled |
---|---|---|---|
Arm/Group Description | Patients who have sedentary life style will treat with Dapoxetine 30 mg (on demand) dapoxetine 30 mg on demand: Dapoxetine, a short-acting selective serotonin reuptake inhibitors, has been utilized for the treatment of premature ejaculation in various countries | Patients who have sedentary life style will be advised moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week. Physical activity: patients will do moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week (To increase the physical activity level to "minimally active category or moderate physical activities [600-3,000 MET-min/week] according to IPAQ classification) | Patients who have sedentary life style will be advised those to walk at most 30 minutes for 5 days in a week. physical activity: patients will do moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week. (inactive category [<600 MET-min/week] according to the IPAQ classification) |
Period Title: Overall Study | |||
STARTED | 42 | 39 | 39 |
COMPLETED | 35 | 35 | 35 |
NOT COMPLETED | 7 | 4 | 4 |
Baseline Characteristics
Arm/Group Title | Group 1 | Group 2 | Sham-controlled | Total |
---|---|---|---|---|
Arm/Group Description | Patients who have sedentary life style will treat with Dapoxetine 30 mg (on demand) dapoxetine 30 mg on demand: Dapoxetine, a short-acting selective serotonin reuptake inhibitors, has been utilized for the treatment of premature ejaculation in various countries | Patients who have sedentary life style will be advised moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week physical activity: patients will do moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week | Patients who have sedentary life style will be advised those to walk at most 30 minutes for 5 days in a week. physical activity: patients will do moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week | Total of all reporting groups |
Overall Participants | 35 | 35 | 35 | 105 |
Age (Count of Participants) | ||||
<=18 years |
0
0%
|
0
0%
|
0
0%
|
0
0%
|
Between 18 and 65 years |
35
100%
|
35
100%
|
35
100%
|
105
100%
|
>=65 years |
0
0%
|
0
0%
|
0
0%
|
0
0%
|
Sex/Gender, Customized (Count of Participants) | ||||
Male |
35
100%
|
35
100%
|
35
100%
|
105
100%
|
Race and Ethnicity Not Collected (Count of Participants) | ||||
Count of Participants [Participants] |
0
0%
|
|||
Region of Enrollment (count of participants) [Number] | ||||
Turkey |
35
100%
|
35
100%
|
35
100%
|
105
100%
|
Outcome Measures
Title | Premature Ejaculation Diagnostic Tool (Total Score) |
---|---|
Description | Premature Ejaculation Diagnostic Tool (PEDT) includes five items; control, frequency, minimal stimulation, distress, and interpersonal difficulty. In this classification tool, equal to or less than scores 8 indicates no PE, scores 9 and 10 indicate possible PE, and scores equal or higher than 11 indicates PE. Total score is between 2 and 22. |
Time Frame | Baseline and 30 Days |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Group 1 | Group 2 | Sham-controlled |
---|---|---|---|
Arm/Group Description | Patients who have sedentary life style will treat with Dapoxetine 30 mg (on demand) dapoxetine 30 mg on demand: Dapoxetine, a short-acting selective serotonin reuptake inhibitors, has been utilized for the treatment of premature ejaculation in various countries | Patients who have sedentary life style will be advised moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week. Physical activity: patients will do moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week (To increase the physical activity level to "minimally active category or moderate physical activities [600-3,000 MET-min/week] according to IPAQ classification) | Patients who have sedentary life style will be advised those to walk at most 30 minutes for 5 days in a week. physical activity: patients will do moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week. (inactive category [<600 MET-min/week] according to the IPAQ classification) |
Measure Participants | 35 | 35 | 35 |
baseline data |
14.5
(1.9)
|
13.7
(1.8)
|
13.7
(2.2)
|
end of study data |
8.9
(2.5)
|
7.8
(2.9)
|
12.8
(1.7)
|
Title | Intravaginal Ejaculatory Latency Time |
---|---|
Description | Duration determined by the sexual partner with stopwatch method, and <1 minute was considered as PE. (minimum/maximum scores were not possible) |
Time Frame | Baseline and 30 Days |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Group 1 | Group 2 | Sham-controlled |
---|---|---|---|
Arm/Group Description | Patients who have sedentary life style will treat with Dapoxetine 30 mg (on demand) dapoxetine 30 mg on demand: Dapoxetine, a short-acting selective serotonin reuptake inhibitors, has been utilized for the treatment of premature ejaculation in various countries | Patients who have sedentary life style will be advised moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week. Physical activity: patients will do moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week (To increase the physical activity level to "minimally active category or moderate physical activities [600-3,000 MET-min/week] according to IPAQ classification) | Patients who have sedentary life style will be advised those to walk at most 30 minutes for 5 days in a week. physical activity: patients will do moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week. (inactive category [<600 MET-min/week] according to the IPAQ classification) |
Measure Participants | 35 | 35 | 35 |
baseline data |
36.8
(13.1)
|
39.3
(8.8)
|
33.8
(14.7)
|
end of study data |
181.7
(88.8)
|
188.6
(82.9)
|
50.3
(19.1)
|
Adverse Events
Time Frame | ||||||
---|---|---|---|---|---|---|
Adverse Event Reporting Description | ||||||
Arm/Group Title | Group 1 | Group 2 | Sham-controlled | |||
Arm/Group Description | Patients who have sedentary life style will treat with Dapoxetine 30 mg (on demand) dapoxetine 30 mg on demand: Dapoxetine, a short-acting selective serotonin reuptake inhibitors, has been utilized for the treatment of premature ejaculation in various countries | Patients who have sedentary life style will be advised moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week physical activity: patients will do moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week | Patients who have sedentary life style will be advised those to walk at most 30 minutes for 5 days in a week. physical activity: patients will do moderate running which make them breathe somewhat harder than normal for at least 30 minutes for 5 days in a week | |||
All Cause Mortality |
||||||
Group 1 | Group 2 | Sham-controlled | ||||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/35 (0%) | 0/35 (0%) | 0/35 (0%) | |||
Serious Adverse Events |
||||||
Group 1 | Group 2 | Sham-controlled | ||||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/35 (0%) | 0/35 (0%) | 0/35 (0%) | |||
Other (Not Including Serious) Adverse Events |
||||||
Group 1 | Group 2 | Sham-controlled | ||||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/35 (0%) | 0/35 (0%) | 0/35 (0%) |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Dr. Muhammet Fatih Kilinc |
---|---|
Organization | Ankara TRH |
Phone | +90 312 595 3700 ext 3724 |
mdfatihkilinc@yahoo.com |
- 5191